Issued Patents All Time
Showing 1–25 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258563 | Modified oligonucleotides | Lauren J. Almeida, David B. Rozema, Omri GOTTESMAN, David L. Lewis | 2025-03-25 |
| 12258564 | GalNAc compositions for improving siRNA bioavailability | David B. Rozema, Omri GOTTESMAN | 2025-03-25 |
| 12188017 | Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin | Christine I. Wooddell, David L. Lewis, Lauren J. Almeida, Steven B. Kanner | 2025-01-07 |
| 12116573 | Targeting ligands for therapeutic compounds | David B. Rozema, Andrei V. Blokhin, Jonathan D. Benson, Zhen Li, Tao Pei +1 more | 2024-10-15 |
| 11879125 | GalNAc compositions for improving siRNA bioavailability | David B. Rozema, Omri GOTTESMAN | 2024-01-23 |
| 11840688 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Steven B. Kanner, Weijun Cheng +7 more | 2023-12-12 |
| 11590156 | RNAi agents for hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2023-02-28 |
| 11534453 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Lauren J. Almeida | 2022-12-27 |
| 11517584 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2022-12-06 |
| 11384355 | Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin | Christine I. Wooddell, David L. Lewis, Lauren J. Almeida, Steven B. Kanner | 2022-07-12 |
| 10927373 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Steven B. Kanner, Weijun Cheng +7 more | 2021-02-23 |
| 10858658 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Lauren J. Almeida | 2020-12-08 |
| 10806750 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Lauren J. Almeida | 2020-10-20 |
| 10780108 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2020-09-22 |
| 10662427 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David B. Rozema, David L. Lewis, Lauren J. Almeida +4 more | 2020-05-26 |
| 10316316 | Compositions for targeted delivery of siRNA | David L. Lewis, David B. Rozema, Torsten Hoffman, Erik Kitas, Peter Mohr +3 more | 2019-06-11 |
| 10308941 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Lauren J. Almeida | 2019-06-04 |
| 10246709 | Targeting ligands for therapeutic compounds | David B. Rozema, Andrei V. Blokhin, Jonathan D. Benson, Zhen Li, Tao Pei +1 more | 2019-04-02 |
| 10130651 | RNAi Therapy for Hepatitis B Virus Infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Lauren J. Almeida | 2018-11-20 |
| 10047361 | Disulfide-containing alkyne linking agents | Aaron Almeida, Andrei V. Blokhin, Jonathan D. Benson, David B. Rozema | 2018-08-14 |
| 10006025 | Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin | Christine I. Wooddell, David L. Lewis, Lauren J. Almeida, Steven B. Kanner | 2018-06-26 |
| 9976141 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Steven B. Kanner, Weijun Cheng +7 more | 2018-05-22 |
| 9932586 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David B. Rozema, David L. Lewis, Lauren J. Almeida +4 more | 2018-04-03 |
| 9803205 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Lauren J. Almeida | 2017-10-31 |
| 9803201 | Disulfide-containing alkyne linking agents | Aaron Almeida, Andrei V. Blokhin, Jonathan D. Benson, David B. Rozema | 2017-10-31 |